LLY compared with PFE: revenue, margins and what each company keeps, and the suppliers and customers both name

LLYELI Lilly & Co

Mkt capRevenueRevenue

PFEPfizer Inc

Mkt capRevenueRevenue

Compare

LLYELI Lilly & Co

PFEPfizer Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

LLY

3 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±5.1%▲+6.63%×1.29

Q2 FY26±6.2%▲+4.86%×0.79

Q1 FY26±5.3%▲+9.80%×1.85

Feb 4 '26±6.1%▲+10.33%×1.69

PFE

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±3.3%▲+1.52%×0.45

Q1 FY26±3.5%▲+0.57%×0.17

= impliedLLY realized, solidPFE realized, hatchedOne scale, both sides: full bar = 11%× = |realized| ÷ impliedSource: market data

Feb 3 '26

±3.2%

▼−3.34%

×1.03

Q3 FY25±4.2%▼−1.46%×0.36

LLYELI Lilly & Co

1,412.87▲+2.85%· post 1,417.05

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

PFEPfizer Inc

30.50▲+1.83%· post 30.46

ClosedOct 30 '26

Mkt cap$174.0BRevenue$15.0BQ2 FY26Revenue$62.6BFY25

Compare

ClosedOct 30 '26

LLYELI Lilly & Co

PFEPfizer Inc

1,412.87▲+2.85%post 1,417.05

Price

30.50▲+1.83%post 30.46

$1.3T

Mkt cap

$174.0B

Q3 FY26$24.4B

Revenue

$15.0BQ2 FY26

FY25$65.2B

Revenue

$62.6BFY25

LLY1,412.87▲+2.85%vsPFE30.50▲+1.83%ClosedOct 30 '26